CATALYST PHARMACEUTICALS, INC. Intellectual Property Contracts & Agreements
11 Contracts & Agreements
- License Agreements (11 contracts)
- License, Supply and Commercialization Agreement between the Company and KYE Pharmaceuticals, Inc., dated as of July 23, 2024 (Filed With SEC on August 7, 2024)
- License & Supply Agreement, dated as of June 28, 2021, between DyDo Pharma, Inc. and the Company (Certain identified information has been excluded from the exhibit because it both... (Filed With SEC on June 30, 2021)
- License & Supply Agreement, dated as of August 14, 2020, between KYE Pharmaceuticals, Inc. and the Company (Certain identified information has been excluded from the exhibit... (Filed With SEC on August 20, 2020)
- Amendment No. 2 to License Agreement, made and entered into effective as of May 29, 2019, by and between BioMarin and the Company (certain identified information has been excluded... (Filed With SEC on May 30, 2019)
- Development, License and Commercialization Agreement by and between the Company and Endo Ventures Limited, dated as of December 18, 2018 (portions of this exhibit have been... (Filed With SEC on December 26, 2018)
- CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by [****]1 AMENDMENT NO. 1 TO LICENSE AGREEMENT (Filed With SEC on April 17, 2014)
- CONFIDENTIAL TREATMENT REQUESTED Redacted portions are indicated by[****]1 LICENSE AGREEMENT (Filed With SEC on January 4, 2013)
- CONFIDENTIAL TREATMENT REQUESTED Redactedportions are indicated by [****]1 LICENSE AGREEMENT (Filed With SEC on October 31, 2012)
- LICENSE AGREEMENT (Filed With SEC on March 30, 2012)
- LICENSE AGREEMENT (Filed With SEC on September 2, 2009)
- EXHIBIT 10.3 LICENSE AGREEMENT (Filed With SEC on July 25, 2006)
